Potential Effectiveness of Chinese Patent Medicine Tongxinluo Capsule for Secondary Prevention After Acute Myocardial Infarction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials-Reference-Cited by-同舟云学术

Potential Effectiveness of Chinese Patent Medicine Tongxinluo Capsule for Secondary Prevention After Acute Myocardial Infarction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Published:2018-08-03 Issue: Volume:9 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Li Min,Li Chengyu,Chen Shiqi,Sun Yang,Hu Jiayuan,Zhao Chen,Qiu Ruijin,Zhang Xiaoyu,Zhang Qin,Tian Guihua,Shang Hongcai

Funder

National Natural Science Foundation of China

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference67 articles.

1. Long-term mortality and hospital readmission after acute myocardial infarction: an eight-year follow-up study;Andrés;Rev. Esp. Cardiol,2012

2. Tongxinluo improves cardiac function and ameliorates ventricular remodeling in mice model of myocardial infarction through enhancing angiogenesis;Bai;Evid. Based Complement Alternat. Med,2013

3. Prognostic impact of β-blocker use in patients with stable coronary artery disease;Bauters;Heart,2014

4. Operating characteristics of a rank correlation test for publication bias;Begg;Biometrics,1994

5. Heart disease and stroke statistics-2017 update: a report from the american heart association;Benjamin;Circulation,2017

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of mitochondrial homeostasis in D-galactose-induced cardiovascular ageing from bench to bedside;Mitochondrion;2024-09

2. Chinese patent medicine Tongxinluo: A review on chemical constituents, pharmacological activities, quality control, and clinical applications;Phytomedicine;2024-09

3. Tongxinluo capsule as a multi-functional traditional Chinese medicine in treating cardiovascular disease: A review of components, pharmacological mechanisms, and clinical applications;Heliyon;2024-07

4. Clinical effects and mechanisms of a Chinese patent medicine, Tongxinluo capsule, as an adjuvant treatment in coronary heart disease;Heliyon;2024-03

5. Anti-inflammatory Therapy Progress in Major Adverse Cardiac Events after PCI: Chinese and Western Medicine;Chinese Journal of Integrative Medicine;2023-05-18